The purpose of this study was to analyze the association of adutt height with cause-specific and total mortality. The study included 31,199 men and women aged 25-64 years who participated in a risk factor survey in 1972, 1977, 1982, or 1987 in eastern Finland. The cohorts were followed until the end of 1994. The relation between height and mortality was assessed by using Cox proportional hazard models. The authors found that height was associated inversely with most of the measured risk factors and directly with socioeconomic status. For both genders, height was Inversely associated with cardiovascular and total mortality; the age-and birthcohort-adjusted risk ratios per 5 cm increase in height were 0.89 and 0.91 for men and 0.86 and 0.90 for women, respectively. The inverse association also remained after adjustment for the other known risk factors. For men, an independent inverse association also was found between height and mortality from chronic obstructive pulmonary disease and from violence and accidents. Cancer mortality was not associated with height. Thus, genetic factors, and environmental factors during the fetal period, childhood, and adolescence, which determine adult height, appear to be related to a person's health later in life. Am J Epidemiol 2OQ0\~\51:1112-20. 
Previous studies have proposed that short stature is associated with poor health. There is fairly strong evidence for an inverse association between adult height and cardiovascular disease risk (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Some studies also have suggested that an inverse association may exist between adult height and the risk of diabetes, pulmonary diseases, and mortality from violent causes, but the data are scarce and the results conflicting (3, 8, 9, (12) (13) (14) (15) . A positive association has been found between adult height and some forms of cancer (16) (17) (18) .
A person's maximum adult height is determined largely by genetic factors. Reaching this genetically determined height, however, depends on environmental factors in utero and during childhood and adolescence (19, 20) . The important role of environmental factors in determining adult height is supported by the finding that the mean height of populations in industrialized countries increased markedly during the 20th century (20, 21) .
The aim of this study was to analyze the association of adult height with mortality from all cardiovascular causes, coronary heart disease, stroke, can-cer, chronic obstructive pulmonary disease (COPD), and violence and accidents and with total mortality. We also analyzed whether the association between height and mortality was independent of the following health-related factors: smoking, serum cholesterol, blood pressure, diabetes, obesity, family history of cardiovascular disease, and socioeconomic status.
MATERIALS AND METHODS

Study populations
Four independent, cross-sectional population surveys (1972,1977,1982, and 1987) were carried out to assess the levels of cardiovascular and other chronic disease risk factors in the North Karelia and Kuopio provinces of eastern Finland (22) . In 1972 and 1977, a randomly selected sample of 6.6 percent (13.2 percent in the city of Joensuu) of the population born between 1913 and 1947 was drawn in both provinces. In 1977, an additional random sample of 6.6 percent of the population bom between 1948 and 1952 was drawn in North Karelia. In 1982 and 1987, the sample included people aged 25-64 years; the samples were stratified according to the World Health Organization Monitoring Trends and Determinants for Cardiovascular Disease protocol: at least 250 subjects of each gender and from each 10-year age group were chosen in both provinces (23) . Thus, the first birth cohort was bom in 1913 and the last one in 1962. The total sample size of the four surveys was 40,592, and 34,968 (86 percent) subjects participated. For the present analyses, the 1,973 subjects who participated in more than one survey were included only in their first survey, and 1,796 subjects were excluded because data on one or more risk factors were missing. Thus, 15,183 men and 16,016 women were included in the present study.
Risk factor assessment
A self-administered questionnaire was mailed to participants in advance. It included questions about smoking and other health-related behaviors, medical history, family history of cardiovascular disease, and socioeconomic factors. At the study site, specially trained nurses measured participants' height, weight, and blood pressure by using a standardized protocol. A venous blood specimen was taken to determine serum cholesterol levels.
A set of standardized questions was used to divide participants into three smoking categories: current smokers, former smokers, and lifelong nonsmokers. In this study, former smokers who had not smoked for 6 months or more were considered nonsmokers, and former smokers who had quit within 6 months were considered current smokers.
Blood pressure was measured on the subject's right arm by using a standard manometer. Height was measured without shoes, and weight was measured with the subject wearing light clothing. Body mass index (kg/m 2 ) was used as a measure of relative body weight. Because the age of subjects during measurement varied according to birth cohort, the possible effect of shrinking in older age on the measurements was assessed by comparing the heights measured at different ages in the same birth cohort.
Serum cholesterol levels were determined in 1972 and 1977 from frozen samples by using the Liebermann-Burchard reaction. In 1982 and 1987, an enzymatic assay method (CHOD-PAP) was used (Monotest; Boehringer Mannheim, Mannheim, Germany). In our laboratory, the enzymatic assay method gave 2.4 percent lower values than the Liebermann-Burchard method; cholesterol values from 1972 and 1977 were corrected by this percentage. All cholesterol determinations were made in the same central laboratory.
Data on family history of coronary heart disease and stroke were obtained from the questionnaire. Positive family history of coronary heart disease was defined as a fatal or nonfatal myocardial infarction or angina pectoris in either parent before age 60 years. Positive family history of cerebrovascular disease was defined as a fatal or nonfatal stroke in either parent before age 60 years.
Years of education and total family income were used as a measure of socioeconomic status. To adjust for changes in the educational system over time, the number of years of schooling was divided into tertiles separately for each birth year, and the birth-cohortspecific distribution was used as the indicator of socioeconomic status. Similarly, family income was divided into approximate tertiles. The mean value of educational level and family income, both in tertiles, was used as an indicator of socioeconomic status. If data were missing on either indicator, socioeconomic status was assessed on the basis of the available indicator.
On the questionnaire, subjects were asked to report the presence of diabetes, including all types and both diet-and drug-treated cases. The data were complemented by records Unking Finland's Social Insurance Institution's register on persons receiving free-of-charge medication for diabetes. These records covered the period 1969-1989 and included drug-treated cases only.
Prospective follow-up
Mortality data were obtained from the national agency Statistics Finland and were linked to the risk factor data by using the identification number assigned to every resident of Finland. The data covered all deaths in Finland and the deaths of Finnish citizens abroad from 1972 to 1994. The Eighth Revision of International Classification of Diseases was used until 1986, and the Ninth Revision was adopted beginning in 1987; codes 390-454 were classified as cardiovascular disease deaths, codes 410-414 as coronary heart disease deaths, codes 430-438 as stroke deaths, codes 140-239 as cancer deaths, codes 490-492 as COPD deaths, and codes 800-999 as violent deaths. During the follow-up period until the end of 1994,3,020 men and 1,555 women died, and a total of 507,603 person-years were cumulated.
Statistics
Analysis of variance was used to test the age-adjusted association between height and the risk factors at baseline. In the prospective follow-up, multivariate analyses were performed by using Cox proportional hazards models (24) . All models were adjusted for age and birth cohort. For the multivariate models, other factors in addition to height, age, and birth cohort were selected on the basis of current knowledge about the etiology of the diseases used as endpoints. The statistical analyses were performed by using SAS statistical software programs (25) .
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.6 cm for men born between 1958 and 1962; for women, height increased from 155.4 to 163.4 cm, respectively (figure 1). In the cohorts born in 1923-1942, subjects were on average about 0.6 cm taller at age 25-49 years as compared with those who were measured at age 50-64 years.
For men, height was found to be inversely associated with smoking, serum cholesterol, and family history of stroke (table 1) , and the association of systolic blood pressure with height was U-shaped. For women, an inverse association was found with serum cholesterol, systolic blood pressure, diabetes prevalence, body mass index, and family history of stroke (table 2) , and the prevalence of smoking tended to increase with increasing height. For both genders, socioeconomic status, as measured by educational level and family income, increased markedly with increasing height 1913 1918 1923 1928 1933 1938 1943 1948 1953 1958 1962 Birth cohort Total mortality decreased continuously as height increased. Per 10,000 person-years, the decrease was from 197 for men shorter than 165 cm to 127 for men taller than 180 cm, and from 93 for women shorter than 150 cm to 56 for women taller than 165 cm. For men, an inverse association was observed between height and cardiovascular mortality, COPD mortality, and mortality from violence and accidents. For women, an inverse association was found between height and cardiovascular mortality. Cancer mortality was not associated with height for either gender.
For men, the age-and birth-cohort-adjusted, heightassociated risk ratios (per 5 cm increase) were 0.89 ( For women, the age-and birth-cohort-adjusted, height-associated risk ratios (per 5 cm increase) were 0.86 (95 percent CI: 0.81, 0.92) for cardiovascular mortality, 0.84 (95 percent CI: 0.78, 0.92) for coronary heart disease mortality, and 0.86 (95 percent CI: 0.76, 0.97) for stroke mortality (table 4) . After adjust- For men, the association of height with cardiovascular and total mortality was stronger when analyses were limited to those who were less than age 55 years at baseline. The risk ratios for all cardiovascular causes, coronary heart disease, stroke, and all-cause mortality were 0. associations (p < 0.05) between height and mortality for some organ-specific cancers. For men, there was a positive association of height with esophagus (19 deaths) and rectum (20 deaths) cancers. For women, there was a negative association of height with stomach (35 deaths) and cervix (10 deaths) cancers, but the association was not statistically significant after adjustment for smoking and socioeconomic status.
DISCUSSION
During about half a century, the mean adult height of men and women increased markedly in eastern Finland. This increase cannot be explained by genetic factors, particularly since the immigration rate for the study area traditionally has been low. Thus, the increase in adult height is mainly due to better nutrition and health in utero and during childhood and adolescence. The observed secular trend in mean adult height in eastern Finland was similar to or even somewhat stronger than that observed for other populations (21).
Short adult stature was associated with high levels of both biologic and behavioral risk factors and with the indicators of socioeconomic status. The inverse association between height and blood pressure, serum cholesterol, and diabetes could have several causes. Genetic factors, metabolic factors originating during the fetal period and early childhood, and nutrition and other health behavior during adulthood may play a role.
It has been observed that babies born small for their gestational age, as compared with normal-size babies, have higher blood pressure, higher cholesterol and blood glucose levels, and an increased risk of coronary heart disease later in life (26, 27) . It has been suggested that relative malnutrition during the fetal period may have long-lasting metabolic effects that predispose persons to coronary disease risk during adulthood. Because adult height is related to birth size, the associations of birth size and of adult height with coronary disease risk may share the same mechanisms. The parents' standard of living and socioeconomic status, as well as the mother's own size, are major determinants of birth size (28) . The effect of socioeconomic status is evident even from one generation to the next; for example, the mother's size, which depends on her (and even her mother's) past nutrition and health, is associated with the size of her newborn baby (29) .
People in higher socioeconomic classes tend to be taller than people in lower socioeconomic classes (30) . In our study, both educational and income levels increased continuously as height increased. The association between height and the indicators of socioeconomic status is most probably due to social class differences in the previous generation. A person's social class correlates with the social class of the parents (31) . Maternal health, the health and nutrition of the child during childhood and adolescence, and, moreover, the extent to which a person can reach his or her genetically determined height are all related to the society's living conditions and the family's socioeconomic status (32) .
However, the causal order may not always be that socioeconomic status determines height. Some studies have shown that the career development of tall subjects is better than that of shorter ones, independent of education (33) . Thus, height per se can influence a person's socioeconomic status. It also can be hypothesized that the same factors, both genetic and environmental, that determine adult height may be linked with the development of the central nervous system during the fetal period and early childhood and further with cognitive function, educational capacity, and professional career later in life. This hypothesis is supported by the recent finding that the nutrition of preterm babies during the neonatal period is associated with cognitive function at school age (34) .
In addition to socioeconomic factors in the past, current socioeconomic status also has a strong influence on health-related factors. Social class is most probably the underlying factor in the association between shortness and a high smoking rate. It also has been observed that the diet between social classes differs. In industrialized countries, higher educated white-collar workers are usually more health conscious and are able to choose healthier food than are less educated bluecollar workers (35) .
Most previous studies have shown an association between height and coronary heart disease (1-12), even though a few studies have reported negative findings (36, 37) . The evidence for the association between height and the risk of stroke is less strong (8) (9) (10) 12) . In our study, both coronary heart disease and stroke mortality were associated with height. About half of this association was independent of the known cardiovascular risk factors. For men, the association between height and coronary heart disease mortality was stronger when the oldest age group, 55-64 years at baseline, was excluded from the analyses. This finding may be explained by selective mortality of shorter men before age 65 years. Until the early 1980s, death from coronary heart disease was not uncommon among middle-aged eastern Finnish men (38) .
Coronary heart disease is markedly more common in eastern Finland than in the western parts of the country (11) . In a prospective study, we recently showed that height, or factors that determine height, can explain a substantial part of the excess coronary heart disease risk for men in eastern Finland as compared with southwestern Finland (11) . Ecologic studies in Norway and Britain have shown that cardiovascular disease mortality is associated with average height as well as with average birth size in these countries (3, 39) . It can be assumed that the factors responsible for the subsequent increase in height may also explain part of the decrease in cardiovascular disease mortality observed in Finland and many other industrialized countries in recent decades (40) .
Our study showed a positive association between height and cancers of the esophagus and rectum and an inverse association between height and cancers of the stomach and cervix. No association was found between height and total cancer mortality or mortality from breast and prostate cancers, which contradicts some other studies (17, (41) (42) (43) . Our findings might partly be explained by the birth cohort effect and the fact that we used cancer mortality instead of cancer incidence as the endpoint. In Finland, survival from several forms of cancer (total cancer, breast, cervix) has improved markedly in recent decades, and the incidence of some forms of cancer (esophagus, stomach) has decreased (44) . Because this has happened concomitantly with increasing height, the better survival and decreasing incidence could be masking the positive association or even showing a negative association between height and cancer mortality. This occurrence, however, does not explain our finding of the positive association of height with esophagus cancer mortality. In recent decades, mortality from esophagus cancer has decreased markedly in Finland, mainly because of the decrease in incidence (44) . The observed association of height with some site-specific cancers also may be due to chance from multiple testing of the hypothesis.
Some previous studies have suggested an association between shortness and pulmonary disease risk (3, 14) . The inverse association between height and death from COPD is partly due to smoking and other factors related to socioeconomic status. Chronic or repeated infections during early life may affect both growth and the risk of pulmonary disease. It is also possible that a pulmonary disease itself can lead to shortness via kyfosis. It has been shown that lung function, which correlates with height, also is associated with coronary heart disease mortality (45) . However, it is controversial as to whether lung function or height is the primary factor in the association with mortality (46) .
Data are scarce on the association between height and mortality from violence and accidents, and the results have been conflicting (15, 47, 48) . Besides socioeconomic factors, psychosocial and cognitive factors also are associated with height (33, 34) and may predispose persons to violent death. A recent study in the United States demonstrated that men who committed suicide were taller than those who died from other causes (47) . In this study, the association of height with death from other causes was not controlled. In some situations, tall people may have a higher physical tolerance for external forces in traffic, home, and occupational accidents than short people do (48) . It has been suggested, however, that tall versus short people may have a higher risk for hip fracture (49) .
The cause-specific variation in the height-mortality association shows not only that impaired growth is a marker of general susceptibility to poor health in adulthood but also that the association is at least partly due to cause-specific mechanisms. Currently, however, these mechanisms are mostly unknown. Even though height is a risk factor that can no longer be modified once a person becomes an adult, the observed association between height and mortality has not only theoretical but also pragmatic consequences. It emphasizes the effect of socioeconomic well-being on health throughout a person's entire life. It also suggests that good maternal and child health care might be important in the prevention of cardiovascular disease, a major public health problem in most developed countries today and a rapidly growing problem in many developing countries. Our study also supports the hypothesis that in addition to physical health, factors that determine adult height also may affect cognitive function and psychological health.
In conclusion, we found that short adult stature was associated with most of the assessed risk factors as well as with socioeconomic status and that it predicted higher mortality. A 1 cm increase in height represented about a 2 percent decrease in mortality. The inverse association between height and mortality partly was mediated through the known risk factors for disease, but height also had a significant independent relation to mortality. Thus, genetic factors, and environmental factors during the fetal period, childhood, and early adolescence, which determine adult height, appear to be related to a person's health later in life.
